Literature DB >> 22015597

Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation.

Tim Kees1, Jennifer Lohr, Johannes Noack, Rodrigo Mora, Georg Gdynia, Grischa Tödt, Aurélie Ernst, Bernhard Radlwimmer, Christine S Falk, Christel Herold-Mende, Anne Régnier-Vigouroux.   

Abstract

The role of microglia, the brain-resident macrophages, in glioma biology is still a matter of debate. Clinical observations and in vitro studies in the mouse model indicate that microglia and macrophages that infiltrate the brain tumor tissue in high numbers play a tumor-supportive role. Here, we provide evidence that human microglia isolated from brain tumors indeed support tumor cell growth, migration, and invasion. However, after stimulation with the Toll-like receptor 3 agonist poly (I:C), microglia secrete factors that exerted toxic and suppressive effects on different glioblastoma cell lines, as assessed in cytotoxicity, migration, and tumor cell spheroid invasion assays. Remarkably, these effects were tumor-specific because the microglial factors impaired neither growth nor viability of astrocytes and neurons. Culture supernatants of tumor cells inhibited the poly (I:C) induction of this microglial M1-like, oncotoxic profile. Microglia stimulation before coculture with tumor cells circumvented the tumor-mediated suppression, as demonstrated by the ability to kill and phagocytose glioma cells. Our results show, for the first time to our knowledge, that human microglia exert tumor-supporting functions that are overridden by tumor-suppressing activities gained after poly (I:C) stimulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22015597      PMCID: PMC3245995          DOI: 10.1093/neuonc/nor182

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  36 in total

1.  Differentiation therapy exerts antitumor effects on stem-like glioma cells.

Authors:  Benito Campos; Feng Wan; Mohammad Farhadi; Aurélie Ernst; Felix Zeppernick; Katrin E Tagscherer; Rezvan Ahmadi; Jennifer Lohr; Christine Dictus; Georg Gdynia; Stephanie E Combs; Violaine Goidts; Burkhard M Helmke; Volker Eckstein; Wilfried Roth; Philipp Beckhove; Peter Lichter; Andreas Unterberg; Bernhard Radlwimmer; Christel Herold-Mende
Journal:  Clin Cancer Res       Date:  2010-05-04       Impact factor: 12.531

Review 2.  Microglia in health and disease.

Authors:  Seung U Kim; Jean de Vellis
Journal:  J Neurosci Res       Date:  2005-08-01       Impact factor: 4.164

3.  End-stage dying glioma cells are engulfed by mouse microglia with a strain-dependent efficacy.

Authors:  Dorothee Nickles; Anette Abschuetz; Heiko Zimmer; Tim Kees; Renate Geibig; Eberhard Spiess; Anne Régnier-Vigouroux
Journal:  J Neuroimmunol       Date:  2008-05-20       Impact factor: 3.478

4.  Th1 polarization of CD4+ T cells by Toll-like receptor 3-activated human microglia.

Authors:  Carolyn S Jack; Nathalie Arbour; Manon Blain; Ute-Christiane Meier; Alexandre Prat; Jack P Antel
Journal:  J Neuropathol Exp Neurol       Date:  2007-09       Impact factor: 3.685

5.  Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes.

Authors:  Kiavash Movahedi; Damya Laoui; Conny Gysemans; Martijn Baeten; Geert Stangé; Jan Van den Bossche; Matthias Mack; Daniel Pipeleers; Peter In't Veld; Patrick De Baetselier; Jo A Van Ginderachter
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

6.  Different angiogenic phenotypes in primary and secondary glioblastomas.

Authors:  Sibylle Karcher; Hans-Herbert Steiner; Rezvan Ahmadi; Saida Zoubaa; Gergely Vasvari; Harry Bauer; Andreas Unterberg; Christel Herold-Mende
Journal:  Int J Cancer       Date:  2006-05-01       Impact factor: 7.396

Review 7.  Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.

Authors:  Alberto Mantovani; Antonio Sica; Paola Allavena; Cecilia Garlanda; Massimo Locati
Journal:  Hum Immunol       Date:  2009-02-21       Impact factor: 2.850

8.  Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit.

Authors:  Hans Herbert Steiner; Matteo Mario Bonsanto; Philipp Beckhove; Michael Brysch; Karsten Geletneky; Rezvan Ahmadi; Rebecca Schuele-Freyer; Paul Kremer; Golamreza Ranaie; Dejana Matejic; Harald Bauer; Marika Kiessling; Stefan Kunze; Volker Schirrmacher; Christel Herold-Mende
Journal:  J Clin Oncol       Date:  2004-09-27       Impact factor: 44.544

9.  Immune infiltrates and cytokines in gliomas.

Authors:  B Giometto; F Bozza; F Faresin; L Alessio; S Mingrino; B Tavolato
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

10.  Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

Authors:  Y Komohara; K Ohnishi; J Kuratsu; M Takeya
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

View more
  36 in total

1.  Engineering Controlled Peritumoral Inflammation to Constrain Brain Tumor Growth.

Authors:  Tarun Saxena; Johnathan G Lyon; S Balakrishna Pai; Daniel Pare; Jessica Amero; Lohitash Karumbaiah; Sheridan L Carroll; Eric Gaupp; Ravi V Bellamkonda
Journal:  Adv Healthc Mater       Date:  2018-12-11       Impact factor: 9.933

2.  Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade.

Authors:  Jorrit De Waele; Elly Marcq; Jonas Rm Van Audenaerde; Jinthe Van Loenhout; Christophe Deben; Karen Zwaenepoel; Erik Van de Kelft; David Van der Planken; Tomas Menovsky; Johan Mj Van den Bergh; Yannick Willemen; Patrick Pauwels; Zwi N Berneman; Filip Lardon; Marc Peeters; An Wouters; Evelien Lj Smits
Journal:  Oncoimmunology       Date:  2017-12-12       Impact factor: 8.110

Review 3.  The role of microglia and macrophages in glioma maintenance and progression.

Authors:  Dolores Hambardzumyan; David H Gutmann; Helmut Kettenmann
Journal:  Nat Neurosci       Date:  2016-01       Impact factor: 24.884

4.  Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies.

Authors:  Marie Duhamel; Mélanie Rose; Franck Rodet; Adriana Natalia Murgoci; Lea Zografidou; Anne Régnier-Vigouroux; Fabien Vanden Abeele; Firas Kobeissy; Serge Nataf; Laurent Pays; Maxence Wisztorski; Dasa Cizkova; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2018-03-12       Impact factor: 5.911

5.  Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells.

Authors:  Susobhan Sarkar; Axinia Döring; Franz J Zemp; Claudia Silva; Xueqing Lun; Xiuling Wang; John Kelly; Walter Hader; Mark Hamilton; Philippe Mercier; Jeff F Dunn; Dave Kinniburgh; Nico van Rooijen; Stephen Robbins; Peter Forsyth; Gregory Cairncross; Samuel Weiss; V Wee Yong
Journal:  Nat Neurosci       Date:  2013-12-08       Impact factor: 24.884

Review 6.  Combination immunotherapy strategies for glioblastoma.

Authors:  Hok Yee Chan; John Choi; Christina Jackson; Michael Lim
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

Review 7.  Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications.

Authors:  Jun Wei; Peiwen Chen; Pravesh Gupta; Martina Ott; Daniel Zamler; Cynthia Kassab; Krishna P Bhat; Michael A Curran; John F de Groot; Amy B Heimberger
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

Review 8.  The molecular profile of microglia under the influence of glioma.

Authors:  Wei Li; Manuel B Graeber
Journal:  Neuro Oncol       Date:  2012-05-09       Impact factor: 12.300

Review 9.  Glioma Cell and Astrocyte Co-cultures As a Model to Study Tumor-Tissue Interactions: A Review of Methods.

Authors:  Ivan V Chekhonin; Dimitry A Chistiakov; Nadezhda F Grinenko; Olga I Gurina
Journal:  Cell Mol Neurobiol       Date:  2018-05-10       Impact factor: 5.046

Review 10.  The roles of microglia/macrophages in tumor progression of brain cancer and metastatic disease.

Authors:  Shih-Ying Wu; Kounosuke Watabe
Journal:  Front Biosci (Landmark Ed)       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.